• Sabra’s Q4 Deals Push 2025 New Investments to $450 Million

    Sabra Health Care REIT released its fourth quarter results. On a year-over-year basis, same-store cash NOI increased 12.6% for the fourth quarter of 2025, while the 2025 quarterly year-over-year average increase was 15.0%, inclusive of the stabilized facilities formerly operated by Holiday Retirement.  Its Q4 acquisitions brought the... Read More »
  • CareTrust Closes 2025 with 169 New Property Investments

    CareTrust REIT came out with its fourth quarter and full-year 2025 earnings and is continuing on its growth trajectory. In Q4, the REIT added 19 properties to its portfolio, comprising 14 triple-net leased skilled nursing facilities, two triple-net leased seniors housing communities and three SHOP communities, all totaling $561.5 million in... Read More »
  • Separate Sellers Divest in Florida

    Berkadia announced two seniors housing closings, both involving communities in the Sunshine State. First, Berkadia represented a Maryland-based private equity investment firm in its divestment of a 130-unit independent living, assisted living and memory care community in the Jacksonville, Florida MSA. The asset was built in 2015. Ross Sanders,... Read More »
  • Idaho IL/AL Community Receives HUD Financing

    Berkadia secured $27.5 million in financing for a seniors housing community in Idaho. The asset comprises 191 independent living and assisted living units, and was 97% occupied at the time of closing. Bianca Andujo and Steve Muth closed the financing through HUD’s 232/223(f) program for a first-time Berkadia client based in Tennessee. The loan... Read More »
  • Welltower Releases Strong Results, Again

    Welltower announced its fourth quarter and full-year 2025 results, which reflected a strong year, as anticipated. Investors seemed to agree, with shares rising to an intraday high of 5.9% above the prior close the day following the release, before finishing up 3.5%.  In the fourth quarter, the REIT saw 400 basis points of average occupancy... Read More »

The Stratification of the Skilled Nursing Facility Market

We have talked a lot of skilled nursing prices reaching an unprecedented peak in 2016, at $99,200 per bed, per our just-released 2017 Senior Care Acquisition Report. But even though the average price per bed has risen to extremely high levels, there remains a large difference between those newly built skilled nursing facilities, as well as those with a very strong Medicare census, compared with lower-quality and older properties. In 2015, the upper quartile for skilled nursing pricing was $123,000 per bed, meaning that 25% of the skilled nursing properties sold were transacted above this price level. The upper quartile jumped again in 2016, this time by 15% to $143,300 per bed. Just five... Read More »
Senior Care And Labor

Senior Care And Labor

No talking about deals, values, stock prices and cap rates, not even Brookdale Senior Living. It’s time to talk labor. I know you usually hear me talking about deals, values, stock prices and cap rates, and let’s not forget Brookdale Senior Living. But I am going to digress a bit from the usual. The entire seniors housing and care business seems to be avoiding what I really believe is going to be a labor meltdown. Cost is one thing, and it is already impacting the bottom line of many providers. But the quality, the training, or lack of, is just something that I think is still missing, and it will begin to poke holes into the marketing pitch for seniors housing and care. For all of... Read More »
What Are the Memory Care Investors Saying?

What Are the Memory Care Investors Saying?

On March 9th, we hosted a webinar entitled “Building or Buying Memory Care,” with moderator Steve Monroe and panelists Clint Malin of LTC Properties, Mark Myers of Marcus & Millichap, Michael Stoller of LCB Senior Living and Matthew Turner of MorningStar Senior Living. The panelists covered a range of topics (you can listen to the discussion here) including the risks of overbuilding, effectiveness of memory care conversions and fill-up risk, among others. But our audience also chimed in, answering three poll questions throughout the webinar. First, when asked if they would build stand-alone MC, assisted living with MC or stand-alone AL, 60% preferred the mix, 32% would build... Read More »
Senior Care And Labor

Ventas Not interested in Brookdale, but Diversicare Soars

We may never know if Ventas was really interested in buying Brookdale Senior Living, but it made little sense. We may never know if Ventas was really interested in buying Brookdale Senior Living, but it was just something we did not think made any sense, so we are glad they publicly said they are not pursuing it. The only thing that made possible sense was to buy a 100 or so properties. But again, would it really be worth it? I still think there are suitors sniffing around, but not at prices that will get shareholders excited. Unless a Chinese investor really wants a large toehold in the U.S. Moving on, have you noticed what has been happening with Diversicare Health Services? Late last... Read More »
Memory Care: Buy or Build?

Memory Care: Buy or Build?

Investors in seniors housing have been flocking to the memory care market, as the sector has experienced unprecedented growth since the Great Recession. They are attracted to its need-based demand, higher rents, private payors and apparent dearth in supply in a number of markets (though given the amount of construction in the last few years that is becoming less and less true). But those investors that are interested in getting into or expanding their holdings in this market are faced with a question: do they build memory care, or buy? That is the topic of our upcoming webinar this Thursday at 1PM aptly named, “Buying or Building Memory Care.” Our moderator Steve Monroe and panelists Clint... Read More »

Brookdale Senior Living Buy-Out in Limbo

It has been far too quiet on the Brookdale Senior Living buy-out front, other than its share price continues to slide as some investors may be giving up on a major capital event or sale of the company at a price point that interests them. The shares are trading at their lowest levels since early January, which, counterintuitively, may make it easier to get a deal done, if that is what the Board wants. We are still sticking with our opinion that only “stupid money” would pay the $20 to $25 per share for the company that several analysts have been saying is the true sum-of-the-parts value, which is why the price needs to come down so that a buyer would be able to offer some sort of premium,... Read More »